What if you invested $1000 in AMGN on Jan 1, 2020?
Explore hypothetical investment results for stocks, ETFs, and more. See real historical data and share your discoveries.
Historical Annual Returns
Over the past 20 years, Amgen Inc. has delivered an average annual return of 10.3%. The stock peaked in 2014 with a massive +40.2% gain, while investors faced a downturn in 2007 (-32.1%). Overall, the stock finished in the green 13 times out of 20 years.
Avg Return
+10.3%
Win Rate
65%
13W - 7L
Best
+40.2%
2014
Worst
-32.1%
2007
Performance Consistency
About Amgen Inc.
Visit Website ↗Amgen is one of the world's leading biotechnology companies. Amgen is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses.
Key Business Segments
Human Therapeutics
Discovers, develops, manufactures, and delivers innovative human therapeutics.
Key Innovations
- ✓Epogen (epoetin alfa), a recombinant protein that stimulates the production of red blood cells.
- ✓Neupogen (filgrastim), a recombinant protein that stimulates the production of white blood cells.
Historical Milestones
Amgen is founded.
Amgen goes public.
Epogen, Amgen's first product, is launched.
Amgen acquires Immunex, expanding its portfolio of inflammatory disease treatments.
Amgen acquires Horizon Therapeutics, a biopharmaceutical company focused on rare, autoimmune and severe inflammatory diseases.